HEE Corporation Announces Selection of Radley Brooks as President.

HUTCHINSON, Kan. -- HEE Corporation (HCCF on OTC Pink Sheets) Board of Directors announced today that they have elected Radley Brooks as President and Chief Executive Officer. Formerly President of Operations for HEE Corp., Mr. Brooks has also served in Multiple Executive positions with Best Buy and Sears Roebuck and Company. He attended Fort Hays State University for general studies, Hutchinson Community College for pre-pharmacy studies, and became a Certified Pharmacy Technician in 1995 prior to attending Kansas University where he majored in Microbiology. In announcing their decision, the Advisory Directors and Board of Directors stated that they are pleased that Mr. Brooks accepted this position. He has the education, training, and background in science necessary to understand and appreciate the significance of the proprietary product HPB-84 for diabetics, along with the management experience required to lead HEE Corp. into the future.

About HEE CORPORATION

The HEE Corporation was founded for the purpose of marketing a new and extremely promising treatment for Type II Diabetes. HEE has acquired the worldwide distribution rights for this diabetic treatment. Just in the United States Type II Diabetes has reached epidemic levels with 18.2 million confirmed cases and an estimated 5 million cases that go undiagnosed. Hundreds of billions of dollars world wide is spent each year on the treatment of this disease.

For more information about the Company contact us @ 620-663-3333 or visit our web site at www.hee-corp.com.

NOTE: Safe Harbor for Forward-Looking Statements--Except for historical information contained herein, the statements in this news release are forward-looking statements that are made pursuant to the safe harbor provisions of the Private Securities Litigation Act of 1995. Forward-looking statements involve known and unknown risks and uncertainties that may cause the company's actual results in the future to differ materially from forecasted results. These risks and uncertainties include, among other things, volatility of prices, product demand, market compensation and risk inherent in the company's international operations.